Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)

H. Ramdani, M. Falk, S. Schatz, M. Tiemann, L. C. Heukamp, E. Schuuring, H. J. Groen, F. Griesinger

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	77-77
Number of pages	1
Journal	Oncology Research and Treatment
Volume	42
Publication status	Published - 2019

Handle.net

@article{eb33f431875d4f34b64547e8fdec640d,

title = "Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)",

author = "H. Ramdani and M. Falk and S. Schatz and M. Tiemann and Heukamp, {L. C.} and E. Schuuring and Groen, {H. J.} and F. Griesinger",

year = "2019",

language = "English",

volume = "42",

pages = "77--77",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "KARGER",

}

TY - JOUR

T1 - Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)

AU - Ramdani, H.

AU - Falk, M.

AU - Schatz, S.

AU - Tiemann, M.

AU - Heukamp, L. C.

AU - Schuuring, E.

AU - Groen, H. J.

AU - Griesinger, F.

PY - 2019

Y1 - 2019

M3 - Meeting Abstract

SN - 2296-5270

VL - 42

SP - 77

EP - 77

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

ER -